Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Therasse

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 5, 2005
Efficiency, quality and bureaucracy: not always in the same bag!!Patrick Therasse
The Lancet. Oncology|October 10, 2002
Quality of life in patients undergoing systemic therapy for advanced breast cancerAndrew Bottomley, Patrick Therasse
Future Oncology (London, England)|January 15, 2016
Servier's pipeline in oncology: moving from research to patientsPatrick Therasse, Jean-Pierre Abastado
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Cancer clinical trial outcomes: any progress in tumour-size assessment?Jaap Verweij, Patrick Therasse, Elizabeth Eisenhauer, et al.
Journal of Translational Medicine|October 7, 2003
Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group MechanismsFrederic Lehmann, Denis Lacombe, Patrick Therasse, et al.
Future Oncology (London, England)|April 22, 2017
The Servier oncology pipeline in 2017Patrick Therasse, Beatrice Perron, Sarah A Novack, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeuticsEvelyne Lerut, Hendrik Van Poppel, Steven Joniau, et al.
The Prostate|June 11, 2005
Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastasesBertrand Tombal, Afshin Rezazadeh, Patrick Therasse, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Critical Reviews in Oncology/Hematology|November 23, 2006
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancerLaura Biganzoli, Robert Coleman, Alessandro Minisini, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|November 5, 2005
Efficiency, quality and bureaucracy: not always in the same bag!!Patrick Therasse
The Lancet. Oncology|October 10, 2002
Quality of life in patients undergoing systemic therapy for advanced breast cancerAndrew Bottomley, Patrick Therasse
Future Oncology (London, England)|January 15, 2016
Servier's pipeline in oncology: moving from research to patientsPatrick Therasse, Jean-Pierre Abastado
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Cancer clinical trial outcomes: any progress in tumour-size assessment?Jaap Verweij, Patrick Therasse, Elizabeth Eisenhauer, et al.
Journal of Translational Medicine|October 7, 2003
Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group MechanismsFrederic Lehmann, Denis Lacombe, Patrick Therasse, et al.
Future Oncology (London, England)|April 22, 2017
The Servier oncology pipeline in 2017Patrick Therasse, Beatrice Perron, Sarah A Novack, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeuticsEvelyne Lerut, Hendrik Van Poppel, Steven Joniau, et al.
The Prostate|June 11, 2005
Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastasesBertrand Tombal, Afshin Rezazadeh, Patrick Therasse, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Critical Reviews in Oncology/Hematology|November 23, 2006
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancerLaura Biganzoli, Robert Coleman, Alessandro Minisini, et al.
Pageof 4